Vericel Corporation (VCEL)
NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 40.74 0.00%
VCEL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.09B
- P/E (TTM)
- 86.68
- Forward P/E
- 48.16
- EPS (TTM)
- $0.47
- Dividend yield
- None
- 52-week range
- 28.95 – 49.32
- Day range
- 39.60 – 41.40
- Volume / Avg
- 647.00K / 503.13K
- Beta
- —
- Shares outstanding
- 51.21M
- Next earnings
- Nov 5, 2026
52-week range
VCEL stock today
On Oct 7, VCEL ended the session at $40.74, adding $0.69 (1.72%), versus the S&P 500's 0.22% decline. At this level, VCEL sits in the middle of its 52-week range of $28.95 to $49.32: 17.4% below the high, set on Jul 30, 2026 and 40.7% above the low. VCEL is up 13.1% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 23.0%.
Vericel trades at 86.7x its trailing twelve-month earnings per share of $0.47. Its forward P/E of 48.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Vericel's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Vericel
Company profileVericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Dominick C. Colangelo Esq.
- Headquarters
- Burlington, MA
- Employees
- 398
- Website
- vcel.com
Analyst forecast
ForecastConsensus (8 analysts)
none
Avg. price target
$60.57+48.67%
- Strong buy 0
- Buy 7
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.02
Vericel peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ALVOAlvotech | 5.85 | -4.72% | $2.09B | vs VCEL |
| BCRXBioCryst Pharmaceuticals Inc. | 8.40 | +5.66% | $2.15B | vs VCEL |
| VIRVir Biotechnology Inc. | 11.52 | -0.69% | $1.95B | vs VCEL |
| NVAXNovavax Inc. | 11.22 | -0.88% | $1.85B | vs VCEL |
| ADMAADMA Biologics Inc | 10.14 | -0.39% | $2.27B | vs VCEL |
| RXRXRecursion Pharmaceuticals Inc. Class A | 4.27 | -7.78% | $2.29B | vs VCEL |
| MESOMesoblast Limited ADR | 13.94 | +2.42% | $1.81B | vs VCEL |
| BEAMBeam Therapeutics Inc. | 24.77 | -1.82% | $2.56B | vs VCEL |
Indexes, lists and sector
Vericel stock FAQ
What is Vericel's stock price today?
VCEL last traded at $40.74 as of Oct 7, 4:00 PM EDT, up 1.72% on the day. Prices are delayed at least 15 minutes.
Does Vericel pay a dividend?
No. Vericel does not currently pay a regular cash dividend.
When is Vericel's next earnings date?
Vericel is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.02.
What is VCEL's P/E ratio?
VCEL trades at a trailing P/E ratio of 86.68 and a forward P/E of 48.16.
Who is Vericel's CEO?
Mr. Dominick C. Colangelo Esq. is the chief executive officer of Vericel Corporation, which has about 398 employees.
Has VCEL ever split its stock?
Yes. The most recent VCEL stock split was a 1-for-20 split on Oct 16, 2013, one of 2 splits on record.
What is the VCEL 52-week high?
The 52-week high for VCEL is $49.32 and the 52-week low is $28.95. The stock is currently 17.4% below its high.